BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
Industry, Sector and Symbol
Industry Closed-End Fund - Equity
Sub-IndustryN/A
SectorFinance
Phone+1-800-8820052
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Blackrock Health Sciences Trust (NYSE:BME) Frequently Asked Questions
What is Blackrock Health Sciences Trust's stock symbol?
Blackrock Health Sciences Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "BME."
How often does Blackrock Health Sciences Trust pay dividends? What is the dividend yield for Blackrock Health Sciences Trust?
Blackrock Health Sciences Trust announced a monthly dividend on Monday, June 3rd. Stockholders of record on Friday, June 14th will be given a dividend of $0.20 per share on Friday, June 28th. This represents a $2.40 annualized dividend and a dividend yield of 6.21%. The ex-dividend date is Thursday, June 13th. View Blackrock Health Sciences Trust's Dividend History.
Has Blackrock Health Sciences Trust been receiving favorable news coverage?
News headlines about BME stock have been trending very negative on Monday, according to InfoTrie. The research group identifies positive and negative press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Blackrock Health Sciences Trust earned a news sentiment score of -3.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 2.0 out of 10, indicating that recent press coverage is very unlikely to have an impact on the company's share price in the immediate future. View News Stories for Blackrock Health Sciences Trust.
Who are some of Blackrock Health Sciences Trust's key competitors?
What other stocks do shareholders of Blackrock Health Sciences Trust own?
Who are Blackrock Health Sciences Trust's key executives?
Blackrock Health Sciences Trust's management team includes the folowing people:
- Mr. John M. Perlowski, Chief Exec. Officer and Pres (Age 55)
- Mr. Neal J. Andrews, Chief Financial Officer (Age 53)
- Mr. Charles Choon Sik Park, Chief Compliance Officer and Anti-Money Laundering Officer (Age 52)
- Mr. Michael D. Carey CFA, Managing Director and Portfolio Mang.
- Mr. Jay M. Fife, Treasurer (Age 49)
Who are Blackrock Health Sciences Trust's major shareholders?
Blackrock Health Sciences Trust's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include First Allied Advisory Services Inc. (0.00%), Cambridge Investment Research Advisors Inc. (0.00%), Raymond James Financial Services Advisors Inc. (0.00%), Janney Montgomery Scott LLC (0.00%), Cetera Advisor Networks LLC (0.00%) and Wealthcare Advisory Partners LLC (0.00%). Company insiders that own Blackrock Health Sciences Trust stock include Alexander Tsakumis and Gary Gordon Cope. View Institutional Ownership Trends for Blackrock Health Sciences Trust.
Which institutional investors are selling Blackrock Health Sciences Trust stock?
Which institutional investors are buying Blackrock Health Sciences Trust stock?
BME stock was acquired by a variety of institutional investors in the last quarter, including Raymond James Financial Services Advisors Inc., Weiss Asset Management LP, Wealthcare Advisory Partners LLC, Cambridge Investment Research Advisors Inc., Janney Montgomery Scott LLC and Cetera Advisor Networks LLC. View Insider Buying and Selling for Blackrock Health Sciences Trust.
How do I buy shares of Blackrock Health Sciences Trust?
Shares of BME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Blackrock Health Sciences Trust's stock price today?
One share of BME stock can currently be purchased for approximately $38.65.
What is Blackrock Health Sciences Trust's official website?
How can I contact Blackrock Health Sciences Trust?
Blackrock Health Sciences Trust's mailing address is 100 Bellevue Pkwy, WILMINGTON, DE 19809-3700, United States. The company can be reached via phone at +1-800-8820052.
MarketBeat Community Rating for Blackrock Health Sciences Trust (NYSE BME)
MarketBeat's community ratings are surveys of what our community members think about Blackrock Health Sciences Trust and other stocks. Vote "Outperform" if you believe BME will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BME will underperform the S&P 500 over the long term. You may vote once every thirty days.
